MYX mayne pharma group limited

Nextstellis figures, page-11

  1. 335 Posts.
    lightbulb Created with Sketch. 266
    "We'd hope MYX with Nextstellis is different - we are just talking about "cycles". Regardless of which way they are reported - the growth rates are similar and unfortunately the last few months have been flat. Reporting type is semantics as the market is wanting revenue growth for a product that has cost Hundreds and Hundreds and Hundreds of $millions."

    The definition of semantics is "meaning the same thing", clearly IQVIA cycles (as presented in May) are 23% lower on average than demand cycles (as presented in Feb), so not the same thing and not semantics. I am sure Mithra would not have been happy to be paid licence fees based on IQVIA cycles which are 23% lower. So cycles ain't cycles.
    As far as cycles growth rates, this year's growth average is 4.6%, not great but not flat and I agree that the market wants to see revenue growth but no figures have been made available but I am sure that if demand cycles had been presented instead of IQVIA cycles, the market might be factoring in revenue growth of a different kind.

 
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)
Last
$5.02
Change
0.020(0.40%)
Mkt cap ! $407.8M
Open High Low Value Volume
$5.05 $5.09 $4.96 $774.1K 154.0K

Buyers (Bids)

No. Vol. Price($)
3 3317 $4.99
 

Sellers (Offers)

Price($) Vol. No.
$5.04 1291 1
View Market Depth
Last trade - 16.10pm 25/06/2025 (20 minute delay) ?
MYX (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.